# Vision Incubate

> Vision Incubate is a VC fund in Kanazawa backing Medical, Therapeutics and Biotechnology. See 6 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Kanazawa, Japan
- Total investments: 6
- Last investment: Jul 2026
- Lead investor: 33%
- Last updated: Aug 2026
- Website: https://visionincubate.com/jp

Vision Incubate is a VC fund in Kanazawa focused on Medical and Therapeutics. Vision Incubate operates as an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 33% |
| Therapeutics | 2 | 33% |
| Biotechnology | 2 | 33% |
| Artificial Intelligence | 2 | 33% |
| B2B | 1 | 17% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 33% |
| Seed | 1 | 17% |
| Pre-Seed | 1 | 17% |
| Series B | 1 | 17% |
| Funding Round | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 5 | 83% |
| United States | 1 | 17% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CORE Biomedicine | CORE Biomedicine is a private, preclinical-stage biotechnology company that specializes in drug discovery and development for oncology. | $21M | Series A | Jul 28, 2026 |  |
| Anaut | Anaut specializes in software development utilizing artificial intelligence for surgical support in surgical medicine. |  | Series B | Mar 01, 2026 |  |
| FerroptoCure | FerroptoCure is a research firm that specializes in ferroptosis research and the development of therapeutic drugs to treat diseases. | $3.1M | Series A | Sep 19, 2025 |  |
| MoveEz | MoveEz develops mapless autonomous driving technology using proprietary perception and decision-making systems. Their solutions enable sustainable, all-weather autonomous mobility without relying on high-precision digital maps. |  | Pre-Seed | Apr 01, 2025 |  |
| THE PHAGE | The phage is a medical device company that focuses on developing AI technology to predict postprandial blood glucose levels. |  | Seed | Sep 12, 2024 |  |
| Optieum Biotechnologies | Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers. Their proprietary platform technology, Eumbody System™, enables to develop and detect a scFv-based product candidates that specifically bind to, and modulate tooptimize the immune-cell function for oncology targets.We are committed to helping patients with severe diseases by bringing life-changing therapies to the patients in need. |  |  |  |  |

6 of 6 investments shown.

## Co-investors
- [ANRI](https://shizune.co/investors/profile/anri) — VC Fund, 2 deals together
- [KSP](https://shizune.co/investors/profile/ksp) — VC Fund, 2 deals together
- [TUSIC](https://shizune.co/investors/profile/tusic) — VC Fund, 2 deals together
- [Beyond Next Ventures](https://shizune.co/investors/profile/beyond-next-ventures) — VC Fund, 1 deal together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 1 deal together
- [CD Capital](https://shizune.co/investors/profile/cd-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Medical Device Investors in Japan](https://shizune.co/investors/medical-device-investors-japan)
- [Medical Device VC Funds in Japan](https://shizune.co/investors/medical-device-vc-funds-japan)

## FAQ

### What does Vision Incubate invest in?

Vision Incubate invests primarily in Medical, Therapeutics and Biotechnology startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Vision Incubate last invest?

The most recent investment recorded for Vision Incubate closed in Jul 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co